(Q47239302)

English

Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis

scientific article published in July 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

author name string

J Walenga

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

G Torri

3

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

O E Dahl

4

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

L Drouet

5

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

J Fareed

6

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

Subcommittee on Control of Anticoagulation, Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

7

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

publication date

1 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

11

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

7

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

1421-1425

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

FDA approves first generic enoxaparin product

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

FDA Approves Generic Enoxaparin

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Recommendations on biosimilar low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

A review of the two major regulatory pathways for non-proprietary low-molecular-weight heparins.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Regulatory considerations for generic or biosimilar low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Differences of present recommendations and guidelines for generic low-molecular-weight heparins: is there room for harmonization

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Overview on guidelines and recommendations for generic low-molecular-weight heparins.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

SASAT (South Asian Society on Atherosclerosis & Thrombosis) proposal for regulatory guidelines for generic low-molecular weight heparins (LMWHs).

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Biosimilar low molecular weight heparin products

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Structural characterization of heparins from different commercial sources

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

A robust method to quantify low molecular weight contaminants in heparin: detection of tris(2-n-butoxyethyl) phosphate

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparin

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Effects on molecular conformation and anticoagulant activities of 1,6-anhydrosugars at the reducing terminal of antithrombin-binding octasaccharides isolated from low-molecular-weight heparin enoxaparin.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Low molecular weight heparins differ substantially: impact on developing biosimilar drugs

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

A comparison of the biological activity of 2 formulations of enoxaparin in 12 healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

How To Find a Needle (or Anything Else) in a Haystack: Two-Dimensional Correlation Spectroscopy-Filtering with Iterative Random Sampling Applied to Pharmaceutical Heparin

1 reference

https://api.crossref.org/works/10.1111%2FJTH.12269

21 January 2018

Identifiers

10.1111/JTH.12269

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/23615078

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47239302&oldid=2147636107"